Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

0
2

Opportunity ID:334936
Opportunity Number:NOT-CA-21-091
Opportunity Title:Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Grant
Category of Funding Activity:Health
Category Explanation:
CFDA Number(s):93.393
93.394
93.395
93.396
93.399
Eligible Applicants:Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:
Agency Code:HHS-NIH11
Agency Name:Department of Health and Human Services
National Institutes of Health
Posted Date:Jul 26, 2021
Last Updated Date:Jul 26, 2021
Estimated Synopsis Post Date:Aug 02, 2021
Fiscal Year:2022
Award Ceiling:$200,000
Award Floor:
Estimated Total Program Funding:$1,000,000
Expected Number of Awards:
Description:The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) with special receipt, referral, and/or review conditions (PAR) to solicit applications for research projects addressing mechanisms that impact cancer risk after bariatric surgery. The goal of the proposed funding announcements is twofold, to promote studies examining the mechanism(s) through which bariatric surgery impacts cancer risk, and to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter term outcomes such as weight loss and diabetes. This Notice of Intent to Publish (NOITP) is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. It should be noted that to facilitate the entry of new investigators, especially new clinical investigators, into the field, preliminary data will not be allowed for R21 applications. Furthermore, applications that include collaborators from fields outside of cancer research will be given special programmatic consideration. A companion R01 PAR will be issued which encompasses a similar research focus but will emphasize more established projects. The FOA is expected to be published in late Summer 2021 with an anticipated application due date in Fall 2021. Details of the planned pre-application webinar will be announced after publication of the FOA. This FOA will utilize the R21 activity code with clinical trial not allowed. Details of the planned FOA are provided below.
Version:1





Visit the Official Webpage For More Details on Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

LEAVE A REPLY

Please enter your comment!
Please enter your name here